According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast ...

Bristol Myers Squibb, GSK and Merck are contributing drug ingredients as part of their deals with the White House but are ...

“The global API manufacturing market is going through some major changes these days,” says Sean O’Brien, COO, Abzena. He ...

The Active Pharmaceutical Ingredients Directory contains more than 5,000 API pharmaceutical companies and 25,000 executives working in the API industry around the world. Published annually and updated ...

As supply chain vulnerabilities intensify and competition accelerates, the cost of this underutilization could risk India's ...

Despite being saddled with tariffs and lagging behind China and the US, European sites offer biopharma suppliers a chance to ...

Union Budget 2026 | Investor attention is expected to turn to active pharmaceutical ingredient (API) makers, specialty drug ...

SK Capital Partners have signed a definitive agreement to divest the Noramco API related assets in a sale to Siegfried (Zofingen Switzerland)The ...

Oslo, Norway, 5 February 2026 Vistin Pharma ASA will release its fourth quarter and preliminary 2025 results on Thursday 12th ...

The project, approved in 2008, was meant to anchor the industry’s next phase of growth. Nearly two decades later, the site remains largely idle ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.